Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    Alzheimer's disease AND RAGE
Show Display Options
Rank Status Study
1 Completed A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: PF-04494700;   Drug: Placebo
2 Recruiting Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Azeliragon;   Drug: Placebo
3 Not yet recruiting 2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
Condition: Alzheimer's Disease
Intervention: Drug: Azeliragon 5mg

Study has passed its completion date and status has not been verified in more than two years.